Culverwell Anthony James — SEC Form 4 filings
SEC reporting owner CIK 1693548. 7 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-12-10 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 106,146 shares, $74,992 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 100,000 shares @ $0.45 ($45,000) in Quoin Pharmaceuticals, Ltd., filed 2024-12-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. (QNRX) | Director | 7 | 2 legs · 106,146 sh · $74,992 | — | 8 |
Form 4 filings — Culverwell Anthony James
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Purchase (P): 6,146 @ $4.88 · Purchase (P): 3,073 (derivative) | EDGAR |
| 2026-08-28 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 31,352 @ $5.15 | EDGAR |
| 2026-02-06 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 21,709 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 13,682 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 7,760 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Purchase (P): 100,000 @ $0.45 · Purchase (P): 100,000 (derivative) · Purchase (P): 100,000 (derivative) | EDGAR |
| 2024-12-10 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 50,714 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1693548 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →